Properties of the EQ-5D-5L when prospective longitudinal data from 28,902 total hip arthroplasty procedures are applied to different European EQ-5D-5L value sets

被引:7
作者
Joelson, Anders [1 ,2 ]
Wildeman, Peter [1 ,2 ]
Sigmundsson, Freyr Gauti [1 ,2 ]
Rolfson, Ola [3 ,4 ,5 ]
Karlsson, Jan [6 ]
机构
[1] Orebro Univ, Sch Med Sci, Orebro, Sweden
[2] Orebro Univ Hosp, Dept Orthoped, Orebro, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Orthoped, Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Dept Orthoped, Gothenburg, Sweden
[5] Swedish Hip Arthroplasty Register, Gothenburg, Sweden
[6] Orebro Univ, Univ Hlth Care Res Ctr, Fac Med & Hlth, Orebro, Sweden
来源
LANCET REGIONAL HEALTH-EUROPE | 2021年 / 8卷
关键词
REPORTED OUTCOME MEASURES; COST-EFFECTIVENESS; VERSION; VALUATION; EUROQOL; IMPACT;
D O I
10.1016/j.lanepe.2021.100165
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The purpose of this study was to evaluate the impact of using different country-specific value sets in EQ-5D-5L based outcome analyses. Methods: We obtained data on patients surgically treated with total hip arthroplasty (THA) between 2017 and 2019 from the national Swedish Hip Arthroplasty Register. Preoperative and one-year postoperative data on a total of 28,902 procedures were available for analysis. The EQ-5D-5L health states were coded to the EQ-5D-5L preference indices using 13 European value sets. The EQ-5D-5L index distributions were then estimated with kernel density estimation. The change in EQ-5D-5L index before and one year after treatment was evaluated with the standardized response mean (SRM). The lifetime gain in quality-adjusted life years (QALYs) was estimated with a 3.5% annual QALY discount rate. Findings: There was a marked variability in means and shapes of the resulting EQ-5D-5L index distributions. There were also considerable differences in the EQ-5D-5L index distribution shape before and after the treat-ment using the same value set. The effect sizes of one-year change (SRM) were similar for all value sets. How-ever, the differences in estimated QALY gains were substantial. Interpretation: The EQ-5D-5L index distributions varied considerably when a single large data set was applied to different European EQ-5D-5L value sets. The most pronounced differences were between the value sets based on experience-based valuation and the value sets based on hypothetical valuation. This illustrates that experience-based and hypothetical value sets are inherently different and also that QALY gains derived with different value sets are not comparable. Our findings are of importance in study planning since the results and conclusions of a study depend on the choice of value set. Funding: None. (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:7
相关论文
共 50 条
  • [22] Estimating a social value set for EQ-5D-5L in Sweden
    Sun, Sun
    Chuang, Ling-Hsiang
    Sahlen, Klas-Goran
    Lindholm, Lars
    Norstrom, Fredrik
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2022, 20 (01)
  • [23] How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
    Eneqvist, Ted
    Nemes, Szilard
    Kaerrholm, Johan
    Burstrom, Kristina
    Rolfson, Ola
    ACTA ORTHOPAEDICA, 2020, 91 (03) : 272 - 278
  • [24] New methods for modelling EQ-5D-5L value sets: An application to English data
    Feng, Yan
    Devlin, Nancy J.
    Shah, Koonal K.
    Mulhern, Brendan
    van Hout, Ben
    HEALTH ECONOMICS, 2018, 27 (01) : 23 - 38
  • [25] EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
    Jiang, Ruixuan
    Rand, Kim
    Kuharic, Maja
    Pickard, A. Simon
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2022, 20 (01)
  • [26] Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease
    Rencz, Fanni
    Lakatos, Peter L.
    Gulacsi, Laszlo
    Brodszky, Valentin
    Kurti, Zsuzsanna
    Lovas, Szilvia
    Banai, Janos
    Herszenyi, Laszlo
    Cserni, Tamas
    Molnar, Tamas
    Pentek, Marta
    Palatka, Karoly
    QUALITY OF LIFE RESEARCH, 2019, 28 (01) : 141 - 152
  • [27] Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries
    Janssen, Mathieu F.
    Bonsel, Gouke J.
    Luo, Nan
    PHARMACOECONOMICS, 2018, 36 (06) : 675 - 697
  • [28] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [29] In search of a common currency: A comparison of seven EQ-5D-5L value sets
    Olsen, Jan Abel
    Lamu, Admassu N.
    Cairns, John
    HEALTH ECONOMICS, 2018, 27 (01) : 39 - 49
  • [30] In varietate concordia - custer analysis of EQ-5D-5L value sets in European Union countries
    Pinheiro, Vera
    Feldens, Tallys
    Haagsma, Juanita A.
    Santos, Joao Vasco
    QUALITY OF LIFE RESEARCH, 2025, 34 (04) : 1091 - 1102